share_log

和黃醫藥：截至2024年2月29日止月份之股份發行人的證券變動月報表

HUTCHMED: Monthly Return of Equity Issuer on Movements in Securities for the month ended February 29, 2024

香港交易所 ·  Mar 1 03:39
Summary by Moomoo AI
和黃醫藥（中國）有限公司於2024年3月1日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年2月29日的資料。報告顯示，公司的法定/註冊股本維持不變，上月底結存及本月底結存均為1,500,000,000股，每股面值0.1美元，總股本為150,000,000美元。此外，根據2015年4月24日通過的股份期權計劃，本月底可行使的股份期權總數為42,161,098股，較上月減少171,400股，因股份期權失效所致。報告中未記錄本月普通股增加或減少的數目，也未有其他類型股份變動。
和黃醫藥（中國）有限公司於2024年3月1日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年2月29日的資料。報告顯示，公司的法定/註冊股本維持不變，上月底結存及本月底結存均為1,500,000,000股，每股面值0.1美元，總股本為150,000,000美元。此外，根據2015年4月24日通過的股份期權計劃，本月底可行使的股份期權總數為42,161,098股，較上月減少171,400股，因股份期權失效所致。報告中未記錄本月普通股增加或減少的數目，也未有其他類型股份變動。
HE HUANG PHARMACEUTICALS (CHINA) CO., LTD. FILED ITS LATEST MONTHLY SECURITIES FLUCTUATION REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON MARCH 1, 2024, COVERING DATA FOR THE YEAR ENDED FEBRUARY 29, 2024. The report shows that the company's regulated/registered share capital remained unchanged, with 1,500,000,000 shares outstanding at the end of last month and cash deposits at the end of this month at $0.1 per share and a total share capital of $150,000,000. In addition, under the share option plan approved on April 24, 2015, the total number of share options exercisable at the end of the month was 42,161,098 shares, a decrease of 171,400 shares from the previous month due to the expiration of the stock options. The report did not record an increase or decrease in ordinary shares for the month and no changes in other types of shares.
HE HUANG PHARMACEUTICALS (CHINA) CO., LTD. FILED ITS LATEST MONTHLY SECURITIES FLUCTUATION REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON MARCH 1, 2024, COVERING DATA FOR THE YEAR ENDED FEBRUARY 29, 2024. The report shows that the company's regulated/registered share capital remained unchanged, with 1,500,000,000 shares outstanding at the end of last month and cash deposits at the end of this month at $0.1 per share and a total share capital of $150,000,000. In addition, under the share option plan approved on April 24, 2015, the total number of share options exercisable at the end of the month was 42,161,098 shares, a decrease of 171,400 shares from the previous month due to the expiration of the stock options. The report did not record an increase or decrease in ordinary shares for the month and no changes in other types of shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more